Mar 01, 2020

From Notion to Knowledge: Cancer Research Saves Lives

Clinical trials at Huntsman Cancer Institute (HCI) help find better ways to prevent, diagnose, and treat cancer by testing the safety and effectiveness of new drugs and treatments. On average, there are between 150–200 clinical trials open to HCI patients at any given time.

Feb 25, 2020

Translational Scholar: Courtney Scaife, MD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Courtney Scaife, MD, was recently honored with a Huntsman Translational Scholar award.

Feb 07, 2020

New CAR-T Target Yields Promising Results for Multiple Myeloma

Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at HCI to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism. In research published in the journal Nature Communications, HCI scientists describe a novel way to treat cancers using chimeric antigen receptor (CAR) T cell therapy.

Jan 13, 2020

Translational Scholar: Randy Jensen, MD, PhD

Huntsman Cancer Institute has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Randy Jensen, MD, PhD, was recently honored with a Huntsman Translational Scholar award.

Sep 30, 2019

International Lifetime Achievement Award in Leukemia Research Awarded to Michael Deininger, MD, PhD

The International Chronic Myeloid Leukemia Foundation (iCMLf) has awarded the prestigious Rowley Prize to Michael Deininger, MD, PhD. Deininger’s selection as the 2019 awardee was announced in February. Formal presentation of the prize occurred at an international scientific conference in Bordeaux, France, earlier this month.

Jun 19, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

Jun 06, 2019

Caring for Patients with a Family History of Pancreatic Cancer

Pancreatic cancer is relatively rare, but chances are likely you care for several patients with a family member who has been diagnosed with pancreatic cancer. New data insights outline pancreas cancer screening strategies for certain patients with a family history of the disease.

May 31, 2019

International Clinical Trial of New Drug for Men with Advanced Prostate Cancer Yields Strong Results

Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.